Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
Publication
, Journal Article
Kileel, EM; Malvestutto, CD; Lo, J; Fitch, KV; Fichtenbaum, CJ; Aberg, JA; Zanni, MV; Martinez, E; Okeke, NL; Kumar, P; Joao, E; Bares, SH ...
Published in: Clin Infect Dis
June 8, 2023
Over 2-years of follow-up, integrase strand transfer inhibitor (INSTI)-use was associated with weight gain among those on an INSTI <2 years at entry (+0.27 kg/m2/year; 95% confidence interval [CI], .22 to .33 vs +0.17 kg/m2/year; 95% CI, .12 to .23; P = .01), but not those on an entry INSTI >2 years.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
June 8, 2023
Volume
76
Issue
11
Start / End Page
2010 / 2013
Location
United States
Related Subject Headings
- Microbiology
- Humans
- HIV-1
- HIV Integrase Inhibitors
- HIV Integrase
- HIV Infections
- Drug Resistance, Viral
- Body Mass Index
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kileel, E. M., Malvestutto, C. D., Lo, J., Fitch, K. V., Fichtenbaum, C. J., Aberg, J. A., … Grinspoon, S. K. (2023). Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). Clin Infect Dis, 76(11), 2010–2013. https://doi.org/10.1093/cid/ciad107
Kileel, Emma M., Carlos D. Malvestutto, Janet Lo, Kathleen V. Fitch, Carl J. Fichtenbaum, Judith A. Aberg, Markella V. Zanni, et al. “Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).” Clin Infect Dis 76, no. 11 (June 8, 2023): 2010–13. https://doi.org/10.1093/cid/ciad107.
Kileel EM, Malvestutto CD, Lo J, Fitch KV, Fichtenbaum CJ, Aberg JA, et al. Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). Clin Infect Dis. 2023 Jun 8;76(11):2010–3.
Kileel, Emma M., et al. “Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).” Clin Infect Dis, vol. 76, no. 11, June 2023, pp. 2010–13. Pubmed, doi:10.1093/cid/ciad107.
Kileel EM, Malvestutto CD, Lo J, Fitch KV, Fichtenbaum CJ, Aberg JA, Zanni MV, Martinez E, Okeke NL, Kumar P, Joao E, Bares SH, Berrner D, Smieja M, Roa JC, McCallum S, Douglas PS, Ribaudo HJ, Grinspoon SK. Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). Clin Infect Dis. 2023 Jun 8;76(11):2010–2013.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
June 8, 2023
Volume
76
Issue
11
Start / End Page
2010 / 2013
Location
United States
Related Subject Headings
- Microbiology
- Humans
- HIV-1
- HIV Integrase Inhibitors
- HIV Integrase
- HIV Infections
- Drug Resistance, Viral
- Body Mass Index
- 3202 Clinical sciences
- 11 Medical and Health Sciences